Related Experiment Video
Updated: Oct 2, 2026

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator
Xin Wang1, Yue Yang, Xiaojian Guo
1George Whipple Laboratory for Cancer Research, Department of Urology and the Cancer Center, University of Rochester, Rochester, New York 14642, USA.
Abstract:
The proline-rich tyrosine kinase 2 (Pyk2) was first identified as a key kinase linked to the MAP kinase and JNK signaling pathways that play important roles in cell growth and adhesion. The linkage between Pyk2 and the androgen receptor (AR), an important transcription factor in prostate cancer progression, however, remains unclear. Here we report that using the full-length androgen receptor-associated protein, ARA55, coregulator as bait, we were able to isolate an ARA55-interacting protein, Pyk2, and demonstrated that Pyk2 could repress AR transactivation via inactivation of ARA55. This inactivation may result from the direct phosphorylation of ARA55 by Pyk2 at tyrosine 43, impairing the coactivator activity of ARA55 and/or sequestering ARA55 to reduce its interaction with AR. Our finding that Pyk2 can indirectly modulate AR function via interaction and/or phosphorylation of ARA55 not only expands the role of Pyk2 in AR-mediated prostate cancer growth but also strengthens the role of ARA55 as an AR coregulator.
Insights
Proline-rich tyrosine kinase 2 (Pyk2) was found to repress androgen receptor (AR) activity by inactivating its coactivator ARA55 through phosphorylation. This discovery highlights Pyk2
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Research
Background:
- Proline-rich tyrosine kinase 2 (Pyk2) is a kinase involved in cell growth and adhesion pathways.
- The relationship between Pyk2 and the androgen receptor (AR), crucial in prostate cancer, is not well understood.
- Androgen receptor-associated protein 55 (ARA55) functions as a coactivator for AR.
Purpose of the Study:
- To investigate the interaction between Pyk2 and AR signaling.
- To determine the mechanism by which Pyk2 influences AR function.
- To elucidate the role of ARA55 in the Pyk2-AR pathway.
Main Methods:
- Used full-length ARA55 as bait to identify interacting proteins via co-immunoprecipitation.
- Investigated the effect of Pyk2 on AR transactivation.
- Examined the phosphorylation of ARA55 by Pyk2 at tyrosine 43.
Main Results:
- Pyk2 was identified as an ARA55-interacting protein.
- Pyk2 represses AR transactivation by inactivating ARA55.
- Pyk2 directly phosphorylates ARA55 at tyrosine 43, impairing its coactivator function and/or reducing its interaction with AR.
Conclusions:
- Pyk2 indirectly modulates AR function through interaction with and phosphorylation of ARA55.
- This finding expands the known roles of Pyk2 in AR-mediated prostate cancer growth.
- The study reinforces the significance of ARA55 as a key AR coactivator.
Related Concept Videos
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Receptor Tyrosine Kinases
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
